Seeking Alpha

Stem cell stocks up premarket on this story: A stem cell treatment developed in Newcastle, U.K.,...

Stem cell stocks up premarket on this story: A stem cell treatment developed in Newcastle, U.K., has restored good vision to eight people who had lost sight in one eye. STEM +5.9%. GERN +1.1%.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector